HemaSphere

HS 2021 cover art V2 resized no crop2

The official open access journal of EHA

HemaSphere, the official open access journal of EHA, aims to support hematology researchers by offering a fast and constructive review process and low publication fees. The journal publishes basic, translational and clinical research of very high level as well as insightful review articles with recommendations for future research and clinical applications.

HemaSphere is fully indexed in PubMed Central (PMC).
The journal has also been selected for coverage in Clarivate Analytics' Emerging Sources Citation Index (ESCI) and is listed on the Directory of Open Access Journals (DOAJ).

EHA members have the opportunity to publish for a discounted fee in HemaSphere.

As a newer journal, HemaSphere has not yet received a 2-year impact factor (Clarivate), but citations to individual articles can be followed in Web of Science. We are encouraged by the citations HemaSphere has received. To read a review of the journal's progress over the last five years, please see this recent Editorial written by the Editors-in-Chief.

HemaSphere is indexed in Scopus with a 2021 CiteScore of 4.4 (September 2021) - CiteScore is using a 4-year window to track citations and is updated monthly.

Read the latest articles

Discover our collection of open access articles published in HemaSphere.

Review articles

Explore our collection of Review articles published by HemaSphere.

Submit your paper

EHA members have the opportunity to publish for a discounted fee in HemaSphere.